Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.

Trial Profile

Multiple-dose Pharmacokinetics of Doripenem During Continuous Venovenous Hemodiafiltration and Molecular Adsorbent Recirculating System in ICU Patients and During Hemodialysis in Longterm Hemodialysis Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2014

At a glance

  • Drugs Doripenem (Primary)
  • Indications Bacterial infections
  • Focus Pharmacokinetics
  • Acronyms DORIPENEM IN CVVH, MARS AND HD
  • Most Recent Events

    • 27 Mar 2014 Trial status changed to completed as reported by ClinicalTrials.gov.
    • 27 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top